Biocon Ltd BIOCON-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 05/27/22 IST
333.00quote price arrow up+7.60 (+2.34%)
Volume
895,936
52 week range
314.80 - 420.25
Loading...
  • Open327.50
  • Day High333.70
  • Day Low327.10
  • Prev Close325.40
  • 52 Week High420.25
  • 52 Week High Date06/11/21
  • 52 Week Low314.80
  • 52 Week Low Date10/25/21

Key Stats

  • Market Cap5,153.42M
  • Shares Out1,200.6M
  • 10 Day Average Volume1.79M
  • Dividend0.50
  • Dividend Yield0.15%
  • Beta-
  • YTD % Change-8.49

KEY STATS

  • Open327.50
  • Day High333.70
  • Day Low327.10
  • Prev Close325.40
  • 52 Week High420.25
  • 52 Week High Date06/11/21
  • 52 Week Low314.80
  • 52 Week Low Date10/25/21
  • Market Cap5,153.42M
  • Shares Out1,200.6M
  • 10 Day Average Volume1.79M
  • Dividend0.50
  • Dividend Yield0.15%
  • Beta-
  • YTD % Change-8.49

RATIOS/PROFITABILITY

  • EPS (TTM)5.44
  • P/E (TTM)61.21
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/30/2022
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest On Biocon Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biocon Limited is an India-based biopharmaceutical company that focuses to treat diabetes, cancer and autoimmune diseases. The Company is also focused on developing novel therapies for diabetes, oncology and immunology. The Company’s businesses segment includes Generics, Biosimilars, Novel Biologics and Research Services. The Company’s Generic Formulations and active pharmaceutical ingredients (API)products include Rosuvastatin, Simvastatin, Atorvastatin, Fingolimod...
Kiran Mazumdar-Shaw
Executive Chairperson of the Board
Siddharth Mittal CPA
Chief Executive Officer, Managing Director, Executive Director
Address
20th KM, Hosur Road, Electronics City
Bangalore
560100
India